Posted on Leave a comment

GSK to buy rare cancer drug developer IDRx for up to £1bn – This is Money

GSK to buy rare cancer drug developer IDRx for up to £1bn  This is Money
source

Leave a Reply

Your email address will not be published. Required fields are marked *